News

News

Backlash Builds Over Biden Plan for Seizing Drug Patents

News

Agenda Setting: Bipartisan Push Back

News

Former officials combine forces to blast march-in rights

News

Public Comments Reveal Widespread Unity in Opposition to NIST’s March-In Rights Framework

News

WTO appears close to rejecting a proposed waiver on patents for Covid diagnostics and therapies

News

KFF Health News: Morning Briefing

News

Iancu, Michel and Other PTAB Masters Panelists Float Ways to Make the System Better

News

The March-In Drug Price Control Narrative Crumbles While Its Damage to American Innovation Grows

News

Proposed ‘price’ criteria for march-in rights poses threat to U.S. innovation, critics say

News

Witnesses Clash Over Potential Pros and Cons of PERA in Senate IP Subcommittee Hearing

Scroll to Top